IRIS Accounts Production v25.1.0.734 12368981 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123689812023-04-30123689812024-04-30123689812023-05-012024-04-30123689812022-06-30123689812022-07-012023-04-30123689812023-04-3012368981ns15:EnglandWales2023-05-012024-04-3012368981ns14:PoundSterling2023-05-012024-04-3012368981ns10:Director12023-05-012024-04-3012368981ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3012368981ns10:SmallEntities2023-05-012024-04-3012368981ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3012368981ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3012368981ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3012368981ns10:FullAccounts2023-05-012024-04-3012368981ns10:Director22023-05-012024-04-3012368981ns10:RegisteredOffice2023-05-012024-04-3012368981ns5:CurrentFinancialInstruments2024-04-3012368981ns5:CurrentFinancialInstruments2023-04-3012368981ns5:Non-currentFinancialInstruments2024-04-3012368981ns5:Non-currentFinancialInstruments2023-04-3012368981ns5:ShareCapital2024-04-3012368981ns5:ShareCapital2023-04-3012368981ns5:RetainedEarningsAccumulatedLosses2024-04-3012368981ns5:RetainedEarningsAccumulatedLosses2023-04-3012368981ns5:CostValuation2023-04-3012368981ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3012368981ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 12368981 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

Pillpharm Limited

Pillpharm Limited (Registered number: 12368981)

Contents of the Financial Statements
for the Year Ended 30 April 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Pillpharm Limited

Company Information
for the Year Ended 30 April 2024







DIRECTORS: Mr. N Chahal
Mr. D Chahal





REGISTERED OFFICE: Office 1
21 Hatherton Street
Walsall
United Kingdom
WS4 2LA





REGISTERED NUMBER: 12368981 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

Pillpharm Limited (Registered number: 12368981)

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £    £   
FIXED ASSETS
Investments 4 1,051,578 1,051,578

CURRENT ASSETS
Debtors 5 30,621 30,621
Cash at bank and in hand 2,736 295
33,357 30,916
CREDITORS
Amounts falling due within one year 6 (170,641 ) (308,856 )
NET CURRENT LIABILITIES (137,284 ) (277,940 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

914,294

773,638

CREDITORS
Amounts falling due after more than
one year

7

(627,910

)

(680,433

)
NET ASSETS 286,384 93,205

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 286,184 93,005
SHAREHOLDERS' FUNDS 286,384 93,205

Pillpharm Limited (Registered number: 12368981)

Balance Sheet - continued
30 April 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 April 2025 and were signed on its behalf by:





Mr. D Chahal - Director


Pillpharm Limited (Registered number: 12368981)

Notes to the Financial Statements
for the Year Ended 30 April 2024


1. STATUTORY INFORMATION

Pillpharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

Pillpharm Limited (Registered number: 12368981)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024


4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 May 2023
and 30 April 2024 1,051,578
NET BOOK VALUE
At 30 April 2024 1,051,578
At 30 April 2023 1,051,578

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Other debtors 30,621 30,621

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts 72,523 72,523
Amounts owed to group undertakings - 157,576
Other creditors 98,118 78,757
170,641 308,856

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans 627,910 680,433

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 627,910 680,433

Pillpharm Limited (Registered number: 12368981)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024


8. RELATED PARTY DISCLOSURES

Included in other debtors is the balance due from the company mentioned below as at 30 April 2024:
- Carter's Green Properties Limited - £30,000 (2023 - £30,000)

Included in other creditors are the balances due to the companies mentioned below as at 30 April 2024:
- TCP Pharma Limited - £45,049 (2023 - £46,907)
- Carter's Green Clinic & Business Centre Limited - £17,470 (2023 - £10,255)
- Ian McArdle Limited - £10,005 (2023 - Nil)

The all above loans are repayable on demand.

Mr Navdeep Chahal and Mr Dalwinder Chahal are the directors of above mentioned companies as at 30 April 2024.

9. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling party are Mr Navdeep and Mr Dalwinder Chahal by virtue of their ownership of 100% of the issued share capital in the company.